CYP7A1 and hyperlipidemia: CYP7A1 and HMGCR mediate the conversion from cholesterol to bile acid in the liver and thus have become potential drug targets to induce lipid-lowering effects in hyperlipidemia (Chambers et al. 2019; Xia et al. 2020; Istvan and Deisenhofer 2001).